扶桑薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/13 | 2,148 | 2,155 | 2,117 | 2,150 | +12 | +0.6% | 20,600 |
| 2024/08/09 | 2,131 | 2,196 | 2,096 | 2,138 | +57 | +2.7% | 34,200 |
| 2024/08/08 | 2,050 | 2,201 | 2,025 | 2,081 | +31 | +1.5% | 86,300 |
| 2024/08/07 | 2,018 | 2,119 | 2,018 | 2,050 | +9 | +0.4% | 19,200 |
| 2024/08/06 | 2,021 | 2,084 | 1,995 | 2,041 | +100 | +5.2% | 28,500 |
| 2024/08/05 | 2,051 | 2,051 | 1,930 | 1,941 | -170 | -8.1% | 63,600 |
| 2024/08/02 | 2,199 | 2,199 | 2,111 | 2,111 | -103 | -4.7% | 33,500 |
| 2024/08/01 | 2,282 | 2,290 | 2,212 | 2,214 | -62 | -2.7% | 17,800 |
| 2024/07/31 | 2,256 | 2,276 | 2,234 | 2,276 | +20 | +0.9% | 25,500 |
| 2024/07/30 | 2,257 | 2,257 | 2,244 | 2,256 | -3 | -0.1% | 16,000 |
| 2024/07/29 | 2,253 | 2,265 | 2,231 | 2,259 | +20 | +0.9% | 13,800 |
| 2024/07/26 | 2,255 | 2,261 | 2,230 | 2,239 | -11 | -0.5% | 12,800 |
| 2024/07/25 | 2,258 | 2,273 | 2,243 | 2,250 | -18 | -0.8% | 18,300 |
| 2024/07/24 | 2,292 | 2,299 | 2,267 | 2,268 | -24 | -1% | 11,800 |
| 2024/07/23 | 2,310 | 2,331 | 2,280 | 2,292 | -13 | -0.6% | 13,800 |
| 2024/07/22 | 2,387 | 2,387 | 2,305 | 2,305 | -93 | -3.9% | 40,100 |
| 2024/07/19 | 2,383 | 2,398 | 2,362 | 2,398 | +16 | +0.7% | 14,300 |
| 2024/07/18 | 2,370 | 2,389 | 2,356 | 2,382 | +7 | +0.3% | 14,800 |
| 2024/07/17 | 2,366 | 2,397 | 2,346 | 2,375 | +26 | +1.1% | 19,400 |
| 2024/07/16 | 2,355 | 2,362 | 2,341 | 2,349 | -2 | -0.1% | 19,200 |
| 2024/07/12 | 2,350 | 2,353 | 2,329 | 2,351 | ±0 | ±0% | 11,800 |
| 2024/07/11 | 2,377 | 2,377 | 2,349 | 2,351 | ±0 | ±0% | 17,000 |
| 2024/07/10 | 2,362 | 2,380 | 2,347 | 2,351 | -18 | -0.8% | 15,200 |
| 2024/07/09 | 2,403 | 2,403 | 2,361 | 2,369 | -13 | -0.5% | 12,000 |
| 2024/07/08 | 2,417 | 2,417 | 2,382 | 2,382 | -35 | -1.4% | 10,600 |
| 2024/07/05 | 2,470 | 2,475 | 2,407 | 2,417 | -44 | -1.8% | 9,800 |
| 2024/07/04 | 2,435 | 2,468 | 2,429 | 2,461 | +26 | +1.1% | 3,700 |
| 2024/07/03 | 2,435 | 2,435 | 2,414 | 2,435 | -5 | -0.2% | 5,300 |
| 2024/07/02 | 2,443 | 2,468 | 2,435 | 2,440 | -3 | -0.1% | 12,200 |
| 2024/07/01 | 2,444 | 2,445 | 2,425 | 2,443 | -1 | ±0% | 8,300 |
| 2024/06/28 | 2,449 | 2,449 | 2,416 | 2,444 | -5 | -0.2% | 14,100 |
| 2024/06/27 | 2,420 | 2,449 | 2,378 | 2,449 | +37 | +1.5% | 21,300 |
| 2024/06/26 | 2,399 | 2,420 | 2,378 | 2,412 | +13 | +0.5% | 13,000 |
| 2024/06/25 | 2,410 | 2,420 | 2,378 | 2,399 | -11 | -0.5% | 18,200 |
| 2024/06/24 | 2,358 | 2,410 | 2,358 | 2,410 | +52 | +2.2% | 16,100 |
| 2024/06/21 | 2,307 | 2,358 | 2,307 | 2,358 | +48 | +2.1% | 15,000 |
| 2024/06/20 | 2,358 | 2,358 | 2,285 | 2,310 | -40 | -1.7% | 18,300 |
| 2024/06/19 | 2,325 | 2,350 | 2,302 | 2,350 | +36 | +1.6% | 15,300 |
| 2024/06/18 | 2,300 | 2,325 | 2,291 | 2,314 | +37 | +1.6% | 12,300 |
| 2024/06/17 | 2,280 | 2,280 | 2,245 | 2,277 | -3 | -0.1% | 7,800 |
| 2024/06/14 | 2,247 | 2,300 | 2,246 | 2,280 | +19 | +0.8% | 16,400 |
| 2024/06/13 | 2,289 | 2,289 | 2,261 | 2,261 | -28 | -1.2% | 10,200 |
| 2024/06/12 | 2,299 | 2,299 | 2,274 | 2,289 | -5 | -0.2% | 6,600 |
| 2024/06/11 | 2,294 | 2,296 | 2,282 | 2,294 | ±0 | ±0% | 3,700 |
| 2024/06/10 | 2,289 | 2,300 | 2,269 | 2,294 | +14 | +0.6% | 8,400 |
| 2024/06/07 | 2,284 | 2,295 | 2,274 | 2,280 | -4 | -0.2% | 1,400 |
| 2024/06/06 | 2,297 | 2,321 | 2,266 | 2,284 | -4 | -0.2% | 12,300 |
| 2024/06/05 | 2,320 | 2,320 | 2,265 | 2,288 | -50 | -2.1% | 14,400 |
| 2024/06/04 | 2,345 | 2,345 | 2,330 | 2,338 | -7 | -0.3% | 5,100 |
| 2024/06/03 | 2,301 | 2,345 | 2,301 | 2,345 | +46 | +2% | 8,400 |
251～
300
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 扶桑薬 | 220,000円 | +1.6% | -12.7% | 4.09% | 8.17倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| アンジェス | 8,200円 | +110.0% | - | 0.00% | - | 8.94倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| ＣＡＮＢＡＳ | 119,700円 | - | - | 0.00% | - | 8.10倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ステムリム | 31,300円 | - | - | 0.00% | - | 2.88倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| オンコリス | 70,800円 | +3771.0% | - | 0.00% | - | 12.34倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム
